Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: An active drug combination with major nonhematologic toxicity

D. C. Ihde, M. H. Cohen, P. A. Bunn, A. M. Bernath, L. E. Broder, J. D. Minna

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: An active drug combination with major nonhematologic toxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences